Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors

被引：0
|
作者：
Coetzee, Marius J. [1 ]
Louw, Vernon J. [2 ]
Gartrell, Kevin [3 ]
Viljoen, Chris D. [1 ]
机构：
[1] Univ Orange Free State, Dept Haematol & Cell Biol, Bloemfontein, South Africa
[2] Univ Free State, Dept Internal Med, Div Clin Haematol, Bloemfontein, South Africa
[3] Louis Leipoldt Med Ctr, Bellville, W Cape, South Africa
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2009年 / 99卷 / 12期
关键词：
IMATINIB MESYLATE; HYPERTENSION; RECEPTORS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [1] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Anna Rychter
    Piotr Jerzmanowski
    Adam Hołub
    Zofia Specht-Szwoch
    Violetta Kalinowska
    Urszula Tęgowska
    Ilona Seferyńska
    Agnieszka Kołkowska-Leśniak
    Ewa Lech-Marańda
    Joanna Góra-Tybor
    Medical Oncology, 2017, 34
  • [2] Adherence assessment in Chronic Myeloid Leukaemia patients treated by tyrosine kinase inhibitors
    Daouphars, M.
    Ouvry, M.
    Lenain, P.
    Rouvet, J.
    Varin, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 414 - 415
  • [3] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Rychter, Anna
    Jerzmanowski, Piotr
    Holub, Adam
    Specht-Szwoch, Zofia
    Kalinowska, Violetta
    Tegowska, Urszula
    Seferynska, Ilona
    Kolkowska-Lesniak, Agnieszka
    Lech-Maranda, Ewa
    Gora-Tybor, Joanna
    MEDICAL ONCOLOGY, 2017, 34 (06)
  • [4] Adverse outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Papaila, Alexa
    Godding, Mark
    Liu, Michael
    HEART, 2021, 107 (20) : 1680 - 1680
  • [5] Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors
    Kuma, A. Benneh-Akwasi
    Amponsah, E.
    Kyeremeh, R.
    Olayemi, E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 67 - 68
  • [6] Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
    Allegra, Sarah
    Dondi, Emma
    Chiara, Francesco
    De Francia, Silvia
    BIOMEDICINES, 2023, 11 (09)
  • [7] Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Casavecchia, Grazia
    Spinosa, Giuseppina
    De Gennaro, Luisa
    Zicchino, Stefano
    Gravina, Matteo
    Magnesa, Michele
    Di Biase, Matteo
    Brunetti, Natale Daniele
    ACTA CARDIOLOGICA, 2022, 77 (02) : 130 - 135
  • [8] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Gianantonio Rosti
    Fausto Castagnetti
    Gabriele Gugliotta
    Michele Baccarani
    Nature Reviews Clinical Oncology, 2017, 14 : 141 - 154
  • [9] Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease
    Leong, Darryl
    Aghel, Nazanin
    Hillis, Christopher
    Siegal, Deborah
    Karampatos, Sarah
    Rangarajan, Sumathy
    Pond, Gregory
    Seow, Hsien
    HEART, 2021, 107 (08) : 667 - 673
  • [10] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Rosti, Gianantonio
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Baccarani, Michele
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (03) : 141 - 154
12345